Login / Signup

A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?

Jie YuHui WangZhi-Gang ChengFang-Yi LiuQin-Ying LiGuang-Zhi HeYan-Chun LuoXiao-Ling YuZhi-Yu HanPing Liang
Published in: European radiology (2021)
• To our knowledge, this is the first multicenter cohort of long-term oncologic outcomes with percutaneous MWA of cT1 RCC. • The predicting model we developed is accurate to predict the long-term DFS and CSS, which can help to provide a better MWA prognostication over routinely available clinical information. • The available evidence shows that microwave ablation of clinical stage T1 RCC is safe and reliable with promising long-term oncologic outcomes, especially for cT1a RCC with excellent 10-year results.
Keyphrases